ClinicalTrials.Veeva

Menu

A Prospective Study on the Treatment of cLM Based on ICG Imaging

N

Nanjing Children's Hospital

Status

Enrolling

Conditions

Lymphatic Malformation

Treatments

Procedure: Indocyanine green-guided partial resection and sclerotherapy
Procedure: Inflow occlusion with perforation of septation and sclerotherapy
Procedure: Perforation of septation and sclerotherapy
Procedure: Partial resection and sclerotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06275022
NanjingCH011665

Details and patient eligibility

About

The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM.

Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.

Researchers will compare difference in curative effect between two groups.

Enrollment

110 estimated patients

Sex

All

Ages

30 days to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

(1) no previous intervention; (2) cLM diagnosed by pretreatment magnetic resonance imaging (MRI); (3)3 to 6 months post-treatment follow-up; (4) Superfacial cLM

Exclusion criteria

(1) history of iodine allergy; (2) syndromic cLM ; (3) severe liver and kidney dysfunction; (4) intralesional hemorrhage; (5) intralesional infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

110 participants in 4 patient groups

Macro/mixed cystic lymphatic A
Experimental group
Description:
Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy
Treatment:
Procedure: Inflow occlusion with perforation of septation and sclerotherapy
Macro/mixed cystic lymphatic B
Active Comparator group
Description:
Perforation of septation and sclerotherapy
Treatment:
Procedure: Perforation of septation and sclerotherapy
Microcystic lymphatic A
Experimental group
Description:
Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy
Treatment:
Procedure: Indocyanine green-guided partial resection and sclerotherapy
Microcystic lymphatic B
Active Comparator group
Description:
Partial resection and sclerotherapy
Treatment:
Procedure: Partial resection and sclerotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Tao Han, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems